Company profile · Tallinn, Estonia

Synlab Estonia

Clinical Diagnostics · Mass Market

Verified 14 Mar 2026 · 3 sources

DiagnosticsClinical

Regional diagnostics network with high-throughput testing workflows, clinical-laboratory density, and Baltic healthcare-system reach.

Contact & location
Website
synlab.ee
LinkedIn
Company page
Lead
Rainar Aamisepp (verified ↗)
Compliance
ISO 15189
Last reviewed
14 Mar 2026 (3mo ago)
Scale
Mass Market
Capabilities
In-vitro Diagnostics · Genetic Testing · Biochemical Screening
Founded
1998
Headcount
201-500
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Rainar Aamisepp

CEO, Region North & East

Check official leadership source
Full addressVeerenni 53a, 10138 Tallinn, Estonia
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source

Official SYNLAB Eesti company information and document set identifying the Tallinn operating address at Veerenni 53a.

Open source
Operating profile

Mass Market

Tallinn, Estonia. Clinical Diagnostics. Review completed on 14 Mar 2026.

2026 technical specializationClinical Diagnostics
Core capabilities
In-vitro DiagnosticsGenetic TestingBiochemical Screening
Editorial note

Clinical Diagnostics

Regional diagnostics network with high-throughput testing workflows, clinical-laboratory density, and Baltic healthcare-system reach.

Editorial note

SYNLAB Estonia is published as a live Tallinn diagnostics operator with accredited laboratory activity, a current Estonia leader, and a documented local address.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 14 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

In-vitro Diagnostics
Genetic Testing
Biochemical Screening
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceOfficial SYNLAB Eesti news release identifying Rainar Aamisepp as the local company leader.Source origin: synlab.eeOpen source
Supporting evidenceOfficial SYNLAB Eesti company information page confirming the accredited Estonia operating entity.Source origin: synlab.eeOpen source
Physical-site evidenceOfficial SYNLAB Eesti company information and document set identifying the Tallinn operating address at Veerenni 53a.Source origin: synlab.eeOpen source
Certification evidenceSYNLAB Eesti company information page referencing accreditation certificate L058.Source origin: synlab.eeOpen source
Infrastructure

Declared infrastructure

Roche / Abbott Automation
NGS Pipelines
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
REVIEW IN PROGRESS 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is Synlab Estonia located?
Synlab Estonia operates from Veerenni 53a, 10138 Tallinn, Estonia, Tallinn, Estonia.
Who runs Synlab Estonia?
Synlab Estonia is led by Rainar Aamisepp, CEO, Region North & East. Verified 14 Mar 2026.
What certifications does Synlab Estonia hold?
Synlab Estonia is documented under ISO 15189.
What does Synlab Estonia do?
Regional diagnostics network with high-throughput testing workflows, clinical-laboratory density, and Baltic healthcare-system reach. Core capabilities: In-vitro Diagnostics, Genetic Testing, Biochemical Screening.
Editorial context

Related technical briefs

Briefs that name Tallinn as a covered market or city.